Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.7%

3 terminated/withdrawn out of 39 trials

Success Rate

86.4%

-0.1% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 19 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
10(90.9%)
Phase 1
1(9.1%)
11Total
N/A(10)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials
NCT05057403Recruiting

UK Imaging Diabetes Study Seeing Diabetes Clearly

Role: lead

NCT07166471Not Yet Recruiting

Global Reference Ranges - Singapore

Role: lead

NCT04369807Completed

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

Role: lead

NCT04597710Active Not Recruiting

Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing

Role: lead

NCT04054310Not ApplicableRecruiting

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Role: lead

NCT05000242Active Not Recruiting

West Hertfordshire Inflammatory Bowel Disease Technology Study

Role: lead

NCT04114682Active Not Recruiting

Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes

Role: lead

NCT05006196Active Not Recruiting

Contrast-Free Magnetic Resonance Imaging for Breast Disease

Role: lead

NCT04137705Completed

MultiOrgan Multi-Parametric MRI Study

Role: lead

NCT05110248Recruiting

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application

Role: lead

NCT03743272Completed

Repeatability and Reproducibility of Multiparametric MRI

Role: lead

NCT07111130Not ApplicableNot Yet Recruiting

Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer

Role: collaborator

NCT07098650Recruiting

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

Role: lead

NCT06899152Not ApplicableRecruiting

HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

Role: collaborator

NCT04786418Not ApplicableCompleted

Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome

Role: collaborator

NCT05479721Active Not Recruiting

LITMUS Imaging Study

Role: collaborator

NCT06144827Not ApplicableWithdrawn

A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Role: collaborator

NCT04451603Completed

LiverMultiScan Analysis of MRI Scans in HCC

Role: collaborator

NCT04341246Completed

Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)

Role: lead

NCT04336618Completed

Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population

Role: lead